
| Juha Jouhki, Chairman of the Board
Born: 1966 Education: M.Sc. (Tech.) Board member since 2002, Chairman of the Board of Directors since 2005 Principal occupation: Managing Director, Biothom Oy Principal employment history: Thominvest Oy and Thomproperties Oy, Partner 19992002, Managing Director 20022009. Contral Clinics Ltd., Managing Director 19961999. Contral Pharma Ltd., Co-founder, Chairman of the Board 19982002. Finncarriers Oy Ab, different positions 19921996. Other simultaneous positions of trust: Dreadnought Finance Oy, Thominvest Oy, Thomcapital Oy, Procarbon AB, Neomedit Oy, Alimetrics Oy, RAM Partners Oy, Chairman of the Board. Northern Antibiotics Oy, Member of the Board. Number of shares held in Biotie |

|
Pauli Marttila, Deputy Chairman of the Board
Born: 1958 Education: M.Sc. (Eng.) Board member since March 2005 Principal occupation: Director, Business Development and Corporate Investments at Sitra, the Finnish Innovation Fund Principal employment history: Sitra Ventures, Director 20062008, Sitra Life Sciences, Director 20052006. Sitra Life Sciences, Corporate Finance, Director 19992004. Neste Corp. (later Fortum Corp.), Management positions in several R&D operations and business operations since 1983, General Manager of New Developments business unit at Neste Chemicals in Finland 19961999. Neste Noptek Venture Capital Fund (Boston, USA), Manager 19931995. Finnish Consulate General (Los Angeles, USA), Assistant Attaché 19841985. Other simultaneous positions of trust: BPM-Group Oy, Chairman of the Board of Directors. Mobidiag Oy, Chairman of the Board of Directors. Bio Fund I-III venture funds, Member of the Investment Committee. Next Wave Funds (New York, USA), Member of the Advisory Board.
Number of shares held in Biotie |
 | Riku Rautsola
Born: 1954 Education: Ph.D. (Econ.) Board member since March 2004 Principal occupation: President and CEO, VIRxSYS Corporation, a leading genetherapy company Principal employment history: Management, sales and research positions in Denmark, Germany, the United States and China over 20 years. Borean Pharma, President and CEO 20032004. Cosmix Molecular Biologicals, CEO since 2001. Boehringer Ingelheim, Beiersdorf and Fresenius, Management positions. Accelerating Access, a public and private initiative of the UN and the pharmaceutical industry, Founding Member and Chairman 20002001. Free Nevirapine for the Prevention of Mother to Child HIV Transmission, Founder. Other simultaneous positions of trust: VIRxSYS, Board member. Number of shares held in Biotie |
 | Piet Serrure
Born: 1954 Education: M.Sc. (Econ.) Board member since March 2004 Principal occupation: Becap Bvba, Managing Director Principal employment history: Benevent (venture capital company) 1985. Parnib (NIB Capital), Director and CEO until 2001. Origo Management, Managing Director 20012006. Managing Director Becap since 2006. 19761985 different positions at Du Pont de Nemours and Arthur Andersen. European Private Equity and Venture Capital Association (EVCA), Member of the Board of Directors until 2004. Other simultaneous positions of trust: Europe Unlimited, Chairman of the Board of Directors. Member of the Board of Directors at Fin. Co, IPTE, Visys, Finalame, Wichard and Hybrigenics.
Number of shares held in Biotie |
 | Ann Hanham
Born: 1952 Education: Ph.D. from the University of British Columbia, MSc from Simon Fraser University, and a BSc from the University of Toronto. She was also Board Certified in Toxicology in 1986. Board member since November 2008 Principal occupation: Managing Director and General Partner of Burrill & Company Principal employment history: Prior to joining Burrill & Company, she was a co-founder and Vice President of Clinical & Regulatory Affairs at InterMune Pharmaceuticals, and prior to that, the Senior Director for Oncology Product Development at Otsuka Pharmaceuticals and the Medical Director for Celtrix Pharmaceuticals. She has also worked for Becton Dickinson in both regulatory and clinical affairs for the monoclonal antibody programme, and as a regulatory toxicologist with the Health Protection Branch of Health and Welfare Canada. Other simultaneous positions of trust: A member of the Board of Directors of Adlyfe, Cardiokine (Observer), elbion NV, Endocyte, Logical Therapeutics, SCYNEXIS and Waterstone.
Number of shares held in Biotie |
 | Bernd Kastler
Born: 1949 Education: Doctorate in law in 1980 from the University of Giessen (Germany). Board member since: November 2008 Principal occupation: Company Director Principal employment history: Dr. Bernd Kastler is the co-founder and present CEO of elbion NV. Prior to this, he was Member of the Executive Board of ASTA Medica AG, the pharmaceutical subsidiary of Degussa AG. His responsibilities included the finance and the human resources areas Other simultaneous positions of trust: Kastler GmbH, controlled company and Managing Director: beloni Konsortial Gesellschaft
Number of shares held in Biotie |
 | Christoph Schröder
Born: 1961 Education: Ph.D. in Finance from the Technische Universität in Berlin and graduated in Business Administration from Ludwig Maximilians-Universität in Munich. Board member since: November 2008 Principal occupation: a General Partner for life sciences of TVMCapital Principal employment history: Prior to this, he was a member of the BASF Pharmas Executive Board (based in London) and was President of two corporate functions: Global Production/Supply Chain and Corporate Marketing. Following BASF Pharmas acquisition by Abbott Laboratories in 2001, Dr. Schroder became a partner with JSB Partners, L.P., a specialized transatlantic investment banking and advisory firm in the life sciences industry, with offices in Berlin, Boston and Munich. Other simultaneous positions of trust: Board seats on behalf of TVM Capital at Probiodrug AG (Halle, Germany) and Riemser AG (Greifswald/Leipzig, Germany).
Number of shares held in Biotie |

| Peter Fellner
Born: 1943 Education: Ph.D. in molecular biology Board member since: October 2009 Principal occupation: Company Director Principal employment history: CEO of Celltech Group Plc from 1990 to 2003, and its Chairman until 2004. CEO of Roche UK from 1986 to 1990, and also served as a Director of a number of other public companies Other simultaneous position of trust: Chairman of Consort Medical Plc, Chairman of Vernalis Plc, Chairman of Astex Therapeutics Ltd, Director of UCB SA, Director of Evotec AG Number of shares held in Biotie ----
Updated November, 2009 |